\-\ Texto\\:\\ \ \(0\)\
\-\ bp\\ 122\\/49\\ \\ hr\\ 88\ \(0\)\
\-\ wt\\ 50\\.2kg\\ \\ ht\\ 154\\.8cm\ \(0\)\
\-\ heart\\:\\ regular\\ rhythym\\ and\\ rate\ \(0\)\
\-\ lungs\\:\\ clear\\ to\\ auscultation\\ bilaterally\ \(0\)\
\-\ continued\\ monitoring\\ to\\ include\\ periodic\\:\ \(0\)\
\-\ \\>physical\\ exam\ \(0\)\
\-\ \\>ophthalmic\\ and\\ funduscopic\\ exam\ \(0\)\
\-\ \\>growth\\ measurements\ \(0\)\
\-\ \\>developmental\\ assessments\ \(0\)\
\-\ \\>school\\ progress\ \(0\)\
\-\ \\>renal\\ us\\/ct\ \(0\)\
\-\ \\>neuroimaging\\ \\(cranial\\ ct\\/mri\\)\ \(0\)\
\-\ surgery\\ and\\ seizure\\ watch\\ dog\\ in\\ the\\ near\\ future\\.\ \(0\)\
\-\ continue\\ medications\\ \\(as\\ above\\)\ \(0\)\
\-\ continue\\ ketogenic\\ diet\\ and\\ use\\ of\\ vns\ \(0\)\
\-\ mri\\ t2\\ axial\\ and\\ coronal\\ showing\\ multiple\\ cortical\\ lesions\\ \\-\\ high\\ signal\\ and\\ mixed\\ signal\\ intensities\\.\ \(0\)\
\-\ mri\\ t1\\ axial\\ showing\\ subependymal\\ calcifications\\/nodules\\ in\\ the\\ lateral\\ ventricles\\.\ \(0\)\
\-\ fdg\\ shows\\ abnormal\\ cerebral\\ glucose\\ metabolism\\ is\\ evident\\ where\\ there\\ are\\ multiple\\ areas\\ of\\ hypometabolism\\ in\\ the\\ regions\\ of\\ the\\ cortical\\ tubers\\.\\ \\ \ \(0\)\
\-\ amt\\ pet\\ scan\\:\\ the\\ region\\ adjacent\\ to\\ tuber\\ \\#7\\ in\\ the\\ left\\ frontal\\ cortex\\ shown\\ in\\ planes\\ 13\\,\\ 14\\,\\ and\\ 15\\ has\\ increased\\ amt\\ uptake\\.\ \(0\)\
\-\ tuberous\\ sclerosis\ \(40\)\
\-\ \\â\\€\\¢\\ migration\\ disorder\ \(0\)\
\-\ \\â\\€\\¢\\ subependymal\\ gray\\ matter\\ heterotopia\ \(0\)\
\-\ \\â\\€\\¢\\ multiple\\ gliomas\ \(0\)\
\-\ \\â\\€\\¢\\ cortical\\ tubers\ \(0\)\
\-\ 14\\ y\\/o\\ girl\\ with\\ history\\ of\\ intractable\\ complex\\ partial\\ seizures\\ beginning\\ at\\ 5\\ months\\ of\\ age\\.\\ otherwise\\ in\\ good\\ general\\ health\\ requiring\\ no\\ hospitalizations\\ or\\ surgeries\\.\\ \\ she\\ uses\\ a\\ vagal\\ nerve\\ stimulator\\ \\(vns\\)\\ which\\ is\\ set\\ at\\ a\\ maximum\\ level\\ and\\ is\\ maintained\\ on\\ a\\ ketogenic\\ diet\\ which\\ have\\ helped\\ to\\ control\\ seizure\\ activity\\.\\ \\ \ \(0\)\
\-\ she\\ has\\ no\\ recent\\ history\\ of\\ cardiac\\,\\ renal\\,\\ or\\ pulmonary\\ difficulties\\.\\ \\ current\\ medications\\ include\\:\\ jolivette\\ tablet\\ \\(progesterone\\)\\,\\ keppra\\,\\ mysoline\\,\\ lamictal\\,\\ clonazepam\\,\\ diazepam\\,\\ and\\ diastat\\.\ \(0\)\
\-\ this\\ 14y\\/o\\ female\\ has\\ had\\ intractable\\ partial\\ seizures\\ that\\ began\\ at\\ 5\\ mos\\ of\\ age\\.\\ \\ the\\ patient\\ is\\ on\\ a\\ significant\\ number\\ of\\ medications\\ as\\ listed\\ above\\.\\ \\ ts\\ is\\ noted\\ to\\ involve\\ many\\ organ\\ systems\\,\\ however\\ only\\ neoplasms\\ of\\ the\\ brain\\ were\\ found\\.\\ \\ these\\ neoplasms\\ included\\:\\ cortical\\ tubers\\ and\\ subependymal\\ nodules\\ \ \(0\)\
\-\ in\\ the\\ evaluation\\ of\\ epilepsy\\,\\ meg\\(magnetoencephalography\\)\\ was\\ used\\ in\\ conjunction\\ with\\ mri\\ to\\ localize\\ the\\ source\\ of\\ the\\ seizures\\.\\ \\ this\\ is\\ important\\ because\\ surgery\\ is\\ being\\ considered\\ in\\ the\\ near\\ future\\.\ \(0\)\
\-\ a\\ video\\ eeg\\ was\\ also\\ performed\\ and\\ the\\ results\\ are\\ as\\ follows\\:\ \(0\)\
\-\ abnormal\\ due\\ to\\ presence\\ of\\:\\ 1\\)\\ several\\ tonic\\ seizures\\,\\ asymmetrical\\,\\ with\\ eye\\ and\\ head\\ deviation\\ to\\ the\\ right\\ and\\ tonic\\ posturing\\ of\\ the\\ right\\ upper\\ extremity\\ accompanied\\ with\\ generalized\\ eeg\\ changes\\;\\ 2\\)\\ right\\-sided\\ eye\\ blinking\\ accompanied\\ with\\ right\\-sided\\ predominant\\ rhythmic\\ eeg\\ activity\\ during\\ sleep\\;\\ 3\\)\\ bilateral\\ eye\\ blinking\\ accompanied\\ with\\ generalized\\ spike\\ wave\\ discharges\\ out\\ of\\ sleep\\;\\ 4\\)\\ diffuse\\ background\\ slowing\\;\\ and\\ 5\\)\\ lack\\ of\\ an\\ organized\\ sleep\\ architecture\\.\ \(0\)\
\-\ her\\ seizures\\ seemed\\ to\\ be\\ refractory\\ to\\ medical\\ treatment\\,\\ and\\ thus\\ a\\ ketogenic\\ diet\\ and\\ vagal\\ nerve\\ stimulation\\ \\(vns\\)\\ were\\ employed\\ and\\ both\\ have\\ proven\\ to\\ suppress\\ seizure\\ activity\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ketogenic\\:\\ 0\\.054082935116358886\ \(0\)\
\-\ vns\\:\\ 0\\.054082935116358886\ \(0\)\
\-\ \\>\\:\\ 0\\.0406424797600817\ \(0\)\
\-\ tubers\\:\\ 0\\.0393719211728106\ \(0\)\
\-\ seizures\\:\\ 0\\.03756497819492677\ \(0\)\
\-\ blinking\\:\\ 0\\.03605529007757259\ \(0\)\
\-\ eeg\\:\\ 0\\.03601889229938686\ \(0\)\
\-\ accompanied\\:\\ 0\\.032270983818877816\ \(0\)\
\-\ diet\\:\\ 0\\.03209815635282447\ \(0\)\
\-\ amt\\:\\ 0\\.031561988283428995\ \(0\)\
\-\ tonic\\:\\ 0\\.031561988283428995\ \(0\)\
\-\ subependymal\\:\\ 0\\.03130028440038154\ \(0\)\
\-\ sleep\\:\\ 0\\.02972531601481213\ \(0\)\
\-\ vagal\\:\\ 0\\.027550416696468967\ \(0\)\
\-\ intractable\\:\\ 0\\.02589207269602658\ \(0\)\
\-\ cortical\\:\\ 0\\.025481184871785786\ \(0\)\
\-\ medications\\:\\ 0\\.02338387802466895\ \(0\)\
\-\ seizure\\:\\ 0\\.023181385408299813\ \(0\)\
\-\ eye\\:\\ 0\\.0219902442154105\ \(0\)\
\-\ activity\\:\\ 0\\.019668997722586127\ \(0\)\
\-\ future\\:\\ 0\\.019378245317222\ \(0\)\
\-\ continue\\:\\ 0\\.01885818324979768\ \(0\)\
\-\ \\:\\:\\ 0\\.018491203533589615\ \(0\)\
\-\ generalized\\:\\ 0\\.018289214732567748\ \(0\)\
\-\ 122\\/49\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ 50\\.2kg\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ 154\\.8cm\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ rhythym\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ us\\/ct\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ calcifications\\/nodules\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ jolivette\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ mysoline\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ lamictal\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ clonazepam\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ diazepam\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ diastat\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ 14y\\/o\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ meg\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ magnetoencephalography\\:\\ 0\\.018027645038786295\ \(0\)\
\-\ neoplasms\\:\\ 0\\.017789817199639735\ \(0\)\
\-\ right\\-sided\\:\\ 0\\.017059826277403378\ \(0\)\
\-\ stimulator\\:\\ 0\\.01661016614193569\ \(0\)\
\-\ rhythmic\\:\\ 0\\.01661016614193569\ \(0\)\
\-\ discharges\\:\\ 0\\.01661016614193569\ \(0\)\
\-\ \\;\\:\\ 0\\.016567862482229807\ \(0\)\
\-\ showing\\:\\ 0\\.016084730066994388\ \(0\)\
\-\ \\)\\:\\ 0\\.016050950129338153\ \(0\)\
\-\ ct\\/mri\\:\\ 0\\.015780994141714497\ \(0\)\
\-\ 14\\:\\ 0\\.015401482276960988\ \(0\)\
\-\ 5\\:\\ 0\\.015338407499657444\ \(0\)\
\-\ funduscopic\\:\\ 0\\.01519268724508509\ \(0\)\
\-\ posturing\\:\\ 0\\.01519268724508509\ \(0\)\
\-\ near\\:\\ 0\\.015122800047238216\ \(0\)\
\-\ tuber\\:\\ 0\\.014736360964278933\ \(0\)\
\-\ assessments\\:\\ 0\\.014363515244863893\ \(0\)\
\-\ hypometabolism\\:\\ 0\\.014363515244863893\ \(0\)\
\-\ keppra\\:\\ 0\\.014363515244863893\ \(0\)\
\-\ spike\\:\\ 0\\.014363515244863893\ \(0\)\
\-\ dog\\:\\ 0\\.014048278680799971\ \(0\)\
\-\ partial\\:\\ 0\\.013976915020240269\ \(0\)\
\-\ hospitalizations\\:\\ 0\\.013775208348234484\ \(0\)\
\-\ progesterone\\:\\ 0\\.013775208348234484\ \(0\)\
\-\ organized\\:\\ 0\\.013534343244642697\ \(0\)\
\-\ suppress\\:\\ 0\\.013534343244642697\ \(0\)\
\-\ tablet\\:\\ 0\\.01331888206742833\ \(0\)\
\-\ ts\\:\\ 0\\.01331888206742833\ \(0\)\
\-\ asymmetrical\\:\\ 0\\.01331888206742833\ \(0\)\
\-\ watch\\:\\ 0\\.01294603634801329\ \(0\)\
\-\ \\â\\€\\¢\\:\\ 0\\.012818113305487837\ \(0\)\
\-\ above\\:\\ 0\\.012809565057782482\ \(0\)\
\-\ intensities\\:\\ 0\\.012782349829253501\ \(0\)\
\-\ epilepsy\\:\\ 0\\.012782349829253501\ \(0\)\
\-\ mos\\:\\ 0\\.012630799783949365\ \(0\)\
\-\ nerve\\:\\ 0\\.012592826693199617\ \(0\)\
\-\ slowing\\:\\ 0\\.012489710067207133\ \(0\)\
\-\ seemed\\:\\ 0\\.012489710067207133\ \(0\)\
\-\ helped\\:\\ 0\\.01235772945138388\ \(0\)\
\-\ neuroimaging\\:\\ 0\\.01223375271965293\ \(0\)\
\-\ uses\\:\\ 0\\.012116864347792095\ \(0\)\
\-\ localize\\:\\ 0\\.012116864347792095\ \(0\)\
\-\ wave\\:\\ 0\\.012116864347792095\ \(0\)\
\-\ mri\\:\\ 0\\.01204463714671546\ \(0\)\
\-\ architecture\\:\\ 0\\.012006297433128954\ \(0\)\
\-\ employed\\:\\ 0\\.012006297433128954\ \(0\)\
\-\ ht\\:\\ 0\\.011901403170577725\ \(0\)\
\-\ ophthalmic\\:\\ 0\\.011901403170577725\ \(0\)\
\-\ conjunction\\:\\ 0\\.011901403170577725\ \(0\)\
\-\ set\\:\\ 0\\.011706494827419596\ \(0\)\
\-\ measurements\\:\\ 0\\.011615591427479241\ \(0\)\
\-\ heterotopia\\:\\ 0\\.011528557451162684\ \(0\)\
\-\ gliomas\\:\\ 0\\.011528557451162684\ \(0\)\
\-\ 88\\:\\ 0\\.01144507688977157\ \(0\)\
\-\ listed\\:\\ 0\\.01144507688977157\ \(0\)\
\-\ background\\:\\ 0\\.01144507688977157\ \(0\)\
\-\ fdg\\:\\ 0\\.011364870932402897\ \(0\)\
\-\ metabolism\\:\\ 0\\.011364870932402897\ \(0\)\
\-\ difficulties\\:\\ 0\\.0112876923475709\ \(0\)\
\-\ predominant\\:\\ 0\\.0112876923475709\ \(0\)\
\-\ wt\\:\\ 0\\.011213320887098761\ \(0\)\
\-\ school\\:\\ 0\\.011213320887098761\ \(0\)\
\-\ periodic\\:\\ 0\\.011141559496891665\ \(0\)\
\-\ multiple\\:\\ 0\\.011041754622572201\ \(0\)\
\-\ maintained\\:\\ 0\\.010940250554533276\ \(0\)\
\-\ beginning\\:\\ 0\\.010877322827198402\ \(0\)\
\-\ stimulation\\:\\ 0\\.010877322827198402\ \(0\)\
\-\ refractory\\:\\ 0\\.010816273822802326\ \(0\)\
\-\ age\\:\\ 0\\.010637670043126\ \(0\)\
\-\ renal\\:\\ 0\\.01050092249267104\ \(0\)\
\-\ surgeries\\:\\ 0\\.010384148886877565\ \(0\)\
\-\ maximum\\:\\ 0\\.010384148886877565\ \(0\)\
\-\ video\\:\\ 0\\.010384148886877565\ \(0\)\
\-\ migration\\:\\ 0\\.010336029260271853\ \(0\)\
\-\ organ\\:\\ 0\\.010243059170135335\ \(0\)\
\-\ planes\\:\\ 0\\.010027597992920965\ \(0\)\
\-\ axial\\:\\ 0\\.009974607264081274\ \(0\)\
\-\ abnormal\\:\\ 0\\.009967657424600866\ \(0\)\
\-\ proven\\:\\ 0\\.009947392035552291\ \(0\)\
\-\ progress\\:\\ 0\\.009870213450720295\ \(0\)\
\-\ has\\:\\ 0\\.00984478509505692\ \(0\)\
\-\ she\\:\\ 0\\.009810986263616248\ \(0\)\
\-\ include\\:\\ 0\\.009804308744500152\ \(0\)\
\-\ deviation\\:\\ 0\\.009759646536057154\ \(0\)\
\-\ health\\:\\ 0\\.009689122658611\ \(0\)\
\-\ monitoring\\:\\ 0\\.009654752273505927\ \(0\)\
\-\ requiring\\:\\ 0\\.009654752273505927\ \(0\)\
\-\ tuberous\\:\\ 0\\.009620950020026968\ \(0\)\
\-\ to\\:\\ 0\\.00960684906517965\ \(0\)\
\-\ follows\\:\\ 0\\.009398794925951722\ \(0\)\
\-\ glucose\\:\\ 0\\.009339515709442003\ \(0\)\
\-\ systems\\:\\ 0\\.009281906554090886\ \(0\)\
\-\ source\\:\\ 0\\.009225875932029302\ \(0\)\
\-\ signal\\:\\ 0\\.009215027935675987\ \(0\)\
\-\ pet\\:\\ 0\\.009171339639427746\ \(0\)\
\-\ auscultation\\:\\ 0\\.008894908599819867\ \(0\)\
\-\ \\(\\:\\ 0\\.008863334064341847\ \(0\)\
\-\ began\\:\\ 0\\.00884842955876147\ \(0\)\
\-\ number\\:\\ 0\\.008715013358621591\ \(0\)\
\-\ thus\\:\\ 0\\.008693599657461477\ \(0\)\
\-\ gray\\:\\ 0\\.008549671647723646\ \(0\)\
\-\ hr\\:\\ 0\\.008510343709220809\ \(0\)\
\-\ surgery\\:\\ 0\\.008486703739714826\ \(0\)\
\-\ \\,\\:\\ 0\\.008303989739794092\ \(0\)\
\-\ involve\\:\\ 0\\.008237273376655323\ \(0\)\
\-\ ventricles\\:\\ 0\\.008220302409754104\ \(0\)\
\-\ current\\:\\ 0\\.008186777236388713\ \(0\)\
\-\ developmental\\:\\ 0\\.008121331978543778\ \(0\)\
\-\ regular\\:\\ 0\\.008057916361483328\ \(0\)\
\-\ included\\:\\ 0\\.008057916361483328\ \(0\)\
\-\ is\\:\\ 0\\.008049152246816113\ \(0\)\
\-\ evident\\:\\ 0\\.007996408273063535\ \(0\)\
\-\ regions\\:\\ 0\\.007996408273063535\ \(0\)\
\-\ control\\:\\ 0\\.007966334352021215\ \(0\)\
\-\ lack\\:\\ 0\\.007951461633556839\ \(0\)\
\-\ were\\:\\ 0\\.007935731438404587\ \(0\)\
\-\ as\\:\\ 0\\.007929923349043728\ \(0\)\
\-\ 13\\:\\ 0\\.007893029379070016\ \(0\)\
\-\ disorder\\:\\ 0\\.007850275422384303\ \(0\)\
\-\ important\\:\\ 0\\.007850275422384303\ \(0\)\
\-\ in\\:\\ 0\\.007755777241845183\ \(0\)\
\-\ exam\\:\\ 0\\.007677848425151486\ \(0\)\
\-\ mixed\\:\\ 0\\.007674689961021538\ \(0\)\
\-\ growth\\:\\ 0\\.007598470339759304\ \(0\)\
\-\ cranial\\:\\ 0\\.007598470339759304\ \(0\)\
\-\ bp\\:\\ 0\\.007586038752691039\ \(0\)\
\-\ have\\:\\ 0\\.0075682538992437294\ \(0\)\
\-\ continued\\:\\ 0\\.007524989748294963\ \(0\)\
\-\ cortex\\:\\ 0\\.0074774297029692625\ \(0\)\
\-\ good\\:\\ 0\\.0074774297029692625\ \(0\)\
\-\ general\\:\\ 0\\.007363154736927429\ \(0\)\
\-\ coronal\\:\\ 0\\.007276120760610873\ \(0\)\
\-\ nodules\\:\\ 0\\.007244414857674339\ \(0\)\
\-\ many\\:\\ 0\\.007182440727827041\ \(0\)\
\-\ where\\:\\ 0\\.007132192750873042\ \(0\)\
\-\ at\\:\\ 0\\.007102841428414926\ \(0\)\
\-\ considered\\:\\ 0\\.007054278954897028\ \(0\)\
\-\ results\\:\\ 0\\.007054278954897028\ \(0\)\
\-\ shown\\:\\ 0\\.007007048454294474\ \(0\)\
\-\ complex\\:\\ 0\\.0069977318560616305\ \(0\)\
\-\ 15\\:\\ 0\\.006970034054205276\ \(0\)\
\-\ uptake\\:\\ 0\\.006942706389967714\ \(0\)\
\-\ use\\:\\ 0\\.006906828456121274\ \(0\)\
\-\ matter\\:\\ 0\\.0068803271378339425\ \(0\)\
\-\ \\#\\:\\ 0\\.0068541648649097925\ \(0\)\
\-\ rate\\:\\ 0\\.006811291391566142\ \(0\)\
\-\ used\\:\\ 0\\.006703853081693174\ \(0\)\
\-\ 7\\:\\ 0\\.006695817748073768\ \(0\)\
\-\ cardiac\\:\\ 0\\.00665610796104493\ \(0\)\
\-\ lungs\\:\\ 0\\.0066171545970966795\ \(0\)\
\-\ which\\:\\ 0\\.006524108741278318\ \(0\)\
\-\ clear\\:\\ 0\\.0064611996178868016\ \(0\)\
\-\ extremity\\:\\ 0\\.006390918138328094\ \(0\)\
\-\ presence\\:\\ 0\\.006343119874145459\ \(0\)\
\-\ sclerosis\\:\\ 0\\.006276718268765532\ \(0\)\
\-\ otherwise\\:\\ 0\\.006276718268765532\ \(0\)\
\-\ and\\:\\ 0\\.006257981794371603\ \(0\)\
\-\ girl\\:\\ 0\\.006143921126768504\ \(0\)\
\-\ because\\:\\ 0\\.00611353438974652\ \(0\)\
\-\ being\\:\\ 0\\.006089545964827319\ \(0\)\
\-\ heart\\:\\ 0\\.006071737523330827\ \(0\)\
\-\ cerebral\\:\\ 0\\.006054082825693397\ \(0\)\
\-\ areas\\:\\ 0\\.0058800555649203825\ \(0\)\
\-\ recent\\:\\ 0\\.005874681081471978\ \(0\)\
\-\ out\\:\\ 0\\.005775161302369154\ \(0\)\
\-\ bilaterally\\:\\ 0\\.005739683514363811\ \(0\)\
\-\ several\\:\\ 0\\.0056177767601684825\ \(0\)\
\-\ t1\\:\\ 0\\.005538845677350192\ \(0\)\
\-\ adjacent\\:\\ 0\\.005525227493117111\ \(0\)\
\-\ found\\:\\ 0\\.005507209845505343\ \(0\)\
\-\ frontal\\:\\ 0\\.00548934955927067\ \(0\)\
\-\ medical\\:\\ 0\\.0053769116565766965\ \(0\)\
\-\ during\\:\\ 0\\.005347667177758299\ \(0\)\
\-\ diffuse\\:\\ 0\\.005290403722648906\ \(0\)\
\-\ brain\\:\\ 0\\.005258387573216282\ \(0\)\
\-\ only\\:\\ 0\\.005254420569498847\ \(0\)\
\-\ her\\:\\ 0\\.005254420569498847\ \(0\)\
\-\ pulmonary\\:\\ 0\\.005105419857300743\ \(0\)\
\-\ evaluation\\:\\ 0\\.005076152956701039\ \(0\)\
\-\ level\\:\\ 0\\.005036582878623583\ \(0\)\
\-\ changes\\:\\ 0\\.00500827807001035\ \(0\)\
\-\ head\\:\\ 0\\.004956239898924123\ \(0\)\
\-\ t2\\:\\ 0\\.00494598930214796\ \(0\)\
\-\ region\\:\\ 0\\.004935789830755241\ \(0\)\
\-\ scan\\:\\ 0\\.004892170675732063\ \(0\)\
\-\ performed\\:\\ 0\\.004872348325618239\ \(0\)\
\-\ 4\\:\\ 0\\.004869063200775144\ \(0\)\
\-\ a\\:\\ 0\\.004866255237038052\ \(0\)\
\-\ however\\:\\ 0\\.004865783344779285\ \(0\)\
\-\ y\\/o\\:\\ 0\\.004839732167320329\ \(0\)\
\-\ history\\:\\ 0\\.004827053323955352\ \(0\)\
\-\ shows\\:\\ 0\\.004804445193719589\ \(0\)\
\-\ high\\:\\ 0\\.004782302783388172\ \(0\)\
\-\ months\\:\\ 0\\.004772886083210772\ \(0\)\
\-\ are\\:\\ 0\\.004764310317094486\ \(0\)\
\-\ significant\\:\\ 0\\.004699073928536244\ \(0\)\
\-\ lesions\\:\\ 0\\.004678037845284147\ \(0\)\
\-\ due\\:\\ 0\\.004663143462071247\ \(0\)\
\-\ these\\:\\ 0\\.0045477396563555015\ \(0\)\
\-\ both\\:\\ 0\\.0044625766680697785\ \(0\)\
\-\ physical\\:\\ 0\\.004287331839634434\ \(0\)\
\-\ increased\\:\\ 0\\.0042750200036802775\ \(0\)\
\-\ bilateral\\:\\ 0\\.004240936051767779\ \(0\)\
\-\ the\\:\\ 0\\.0042407756044056995\ \(0\)\
\-\ upper\\:\\ 0\\.0042169335488112854\ \(0\)\
\-\ 1\\:\\ 0\\.004158131631819442\ \(0\)\
\-\ noted\\:\\ 0\\.004141965620557452\ \(0\)\
\-\ or\\:\\ 0\\.004096207562223753\ \(0\)\
\-\ 3\\:\\ 0\\.004091974492242413\ \(0\)\
\-\ was\\:\\ 0\\.004042034855679701\ \(0\)\
\-\ this\\:\\ 0\\.003931031547297068\ \(0\)\
\-\ lateral\\:\\ 0\\.00377641727121585\ \(0\)\
\-\ had\\:\\ 0\\.003770654027077113\ \(0\)\
\-\ 2\\:\\ 0\\.0037629948803896652\ \(0\)\
\-\ \\-\\:\\ 0\\.00374586596872876\ \(0\)\
\-\ right\\:\\ 0\\.0036876552519853447\ \(0\)\
\-\ female\\:\\ 0\\.0035925567923268584\ \(0\)\
\-\ of\\:\\ 0\\.003573736220797191\ \(0\)\
\-\ treatment\\:\\ 0\\.0035370489971388286\ \(0\)\
\-\ no\\:\\ 0\\.0035191989803836487\ \(0\)\
\-\ also\\:\\ 0\\.00344502984390624\ \(0\)\
\-\ that\\:\\ 0\\.0030183654980753035\ \(0\)\
\-\ on\\:\\ 0\\.0029606994370774157\ \(0\)\
\-\ be\\:\\ 0\\.002694799025243209\ \(0\)\
\-\ there\\:\\ 0\\.0026006453097443534\ \(0\)\
\-\ an\\:\\ 0\\.0024164925649994475\ \(0\)\
\-\ left\\:\\ 0\\.001955225499535613\ \(0\)\
\-\ patient\\:\\ 0\\.001751721740115313\ \(0\)\
\-\ with\\:\\ 0\\.0014356340624526347\ \(0\)\
\-\ \\.\\:\\ 0\\.0012341352017482346\ \(0\)\
